Related Experiment Video

Updated: Sep 15, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Impact of statins in the liver: A bane or a boon?

George Zacharia1, Anu Jacob2, Manivarnan Karichery3

  • 1Medical Gastroenterology, Ahalia Hospital, Abu Dhabi, UAE.

Canadian Liver Journal
|July 18, 2025
PubMed

Insights

Statins are crucial for managing high cholesterol and cardiovascular disease by inhibiting cholesterol synthesis. Despite rare liver injury risks, extensive evidence confirms statins

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiology
  • Hepatology

Background:

  • Statins are primary treatments for hypercholesterolemia and atherosclerotic cardiovascular diseases.
  • They function by inhibiting HMG-CoA reductase, a key enzyme in cholesterol biosynthesis.
  • Statins possess beneficial pleiotropic effects beyond lipid reduction, including anti-inflammatory and antioxidant properties.

Purpose of the Study:

  • To provide a comprehensive review of statins.
  • To elucidate their mechanism of action and pleiotropic effects.
  • To address concerns regarding statin-induced liver injury (SILI) and explore their therapeutic potential in liver conditions.

Main Methods:

  • Literature review of scientific evidence on statin mechanisms, safety, and efficacy.
  • Analysis of data on incidence and types of statin-associated hepatic adverse events.
  • Evaluation of studies on statins' role in managing liver-related diseases.

Main Results:

  • Statins are effective in lowering cholesterol and have pleiotropic benefits.
  • Statin-induced liver injury (SILI) is rare, with an incidence below 1%.
  • Observed hepatic adverse effects are typically mild and reversible; severe outcomes are very uncommon.

Conclusions:

  • The evidence overwhelmingly supports the safety and benefits of statins.
  • Concerns about widespread statin hepatotoxicity are largely unfounded.
  • Statins demonstrate therapeutic value in managing conditions like non-alcoholic fatty liver disease.

Keywords:
DILIHMG-CoA reductasehepatic adaptationhepatotoxicitystatins

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.6K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
227
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
694
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
286
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.3K